| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |